However, recent studies have suggested that patients prescribed AOMs may regain weight in the months after stopping taking these medications
Novel strategies have also been employed to enhance the pharmacokinetic profile of GLP-1/glucagon analogues in view of prolongation of drug effect
Among those patients taking semaglutide for obesity, 37.4 percent managed to lose at least 10 percent of their body weight after a year, and 16.6 percent of patients taking semaglutide for type 2 diabetes did so too
RMD Open 8(2022)
Less effective than semaglutide in studies (6.4% weight loss vs 12.4%)
Key Benefits Supports tissue integrity and renewal Promotes healthy cellular signaling Supports gastrointestinal barrier function Designed for muscle, joint, and gut support Convenient oral capsule format Supplement Facts Serving Size: 1 Capsule Servings Per Container: 30/60 Other Ingredients: Hypromellose, Microcrystalline Cellulose, Vegetable Stearate, Silica, Salcaprozate Sodium